Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 randomized double-blind trial of SCO-094 in type 2 diabetes
jRCT1080225227Phase 1Completed
- Sponsor
- SCOHIA PHARMA, Inc.
- Start
- Jun 2020
- Modality
- Peptides
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing SCO-094 with Placebo (2 arms). Started Jun 2020; status: completed.
02
Drugs
SCO-094
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080225227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225227.